contraceptives

Bayer Invests in Contraceptives Production

Bayer’s pharmaceuticals division is spending more than €400 million to expand its production facilities for contraceptives in low and middle-income countries, in partnership with international organizations such as the United Nations Population Fund and the United States Agency for International Development.

FDA Approves Mylan’s Yasmin Copies

Actavis to Sell Generic Yaz Birth Control After Ruling

Swiss Health Insurer Makes Claim Against Bayer Over Yasmin Pill

Bayer Sues Lupin Over Generic Birth Control Pill